Patent: 10,071,953
✉ Email this page to a colleague
Summary for Patent: 10,071,953
Title: | Bifunctional AKR1C3 inhibitors/androgen receptor modulators and methods of use thereof |
Abstract: | The invention includes compositions comprising selective AKR1C3 inhibitors. The invention also includes compositions comprising bifunctional AKR1C3 inhibitors and selective androgen receptor modulators. The invention further includes methods of treatment using the compositions of the invention. |
Inventor(s): | Penning; Trevor M. (Springfield, PA), Adeniji; Adegoke O. (Drexel Hill, PA), Byrns; Michael C. (Philadelphia, PA), Winkler; Jeffrey (Wynnewood, PA), Twenter; Barry (Philadelphia, PA) |
Assignee: | The Trustees of the University of Pennsylvania (Philadelphia, PA) |
Application Number: | 14/993,742 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,071,953 |
Patent Claims: | see list of patent claims |
Details for Patent 10,071,953
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | AVASTIN | bevacizumab | Injection | 125085 | 02/26/2004 | ⤷ Try a Trial | 2031-04-13 |
Dendreon Pharmaceuticals Llc | PROVENGE | sipuleucel-t | Injection | 125197 | 04/29/2010 | ⤷ Try a Trial | 2031-04-13 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |